GB1014233A - Urea-containing diuretic compositions - Google Patents

Urea-containing diuretic compositions

Info

Publication number
GB1014233A
GB1014233A GB297564A GB297564A GB1014233A GB 1014233 A GB1014233 A GB 1014233A GB 297564 A GB297564 A GB 297564A GB 297564 A GB297564 A GB 297564A GB 1014233 A GB1014233 A GB 1014233A
Authority
GB
United Kingdom
Prior art keywords
urea
mannitol
diuretic compositions
compositions
containing diuretic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB297564A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
RECH S EXPERIMENTALES GOULDEN
Original Assignee
RECH S EXPERIMENTALES GOULDEN
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by RECH S EXPERIMENTALES GOULDEN filed Critical RECH S EXPERIMENTALES GOULDEN
Publication of GB1014233A publication Critical patent/GB1014233A/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/17Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

A pharmaceutical composition, for use as a diuretic and cerebral decompression agent, comprises urea and mannitol in aqueous solution. Preferred concentrations of the active agents are area, 30% w/w with mannitol, 10% w/w, the solution being intended for intravenous administration.
GB297564A 1963-01-23 1964-01-23 Urea-containing diuretic compositions Expired GB1014233A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR75007645 1963-01-23

Publications (1)

Publication Number Publication Date
GB1014233A true GB1014233A (en) 1965-12-22

Family

ID=8572536

Family Applications (1)

Application Number Title Priority Date Filing Date
GB297564A Expired GB1014233A (en) 1963-01-23 1964-01-23 Urea-containing diuretic compositions

Country Status (1)

Country Link
GB (1) GB1014233A (en)

Similar Documents

Publication Publication Date Title
FI51190C (en) Process for the preparation of therapeutically active, in particular N- (3,4,5-trimethoxy-cinnamoyl) -piperazine derivatives of the coronadilator.
AR194342A1 (en) COMPOSITION TO FIGHT PLANT PATHOGENES AND A NEW TETRAZOLINE (1,5-A) QUINOLINE COMPOUND USEFUL TO FORMULATE SUCH COMPOSITION
GB1014233A (en) Urea-containing diuretic compositions
IL27457A (en) Pharmaceutical and veterinary compositions containing 6-(6&#39;-oxo-10&#39;-hydroxy-undec-1&#39;-enyl)-2,4-dihydroxy-benzoic acid lactone or derivatives thereof together with other active ingredients
ES2128353T3 (en) TOPIC COMPOSITION CONTAINING PENCICLOVIR.
PT65737A (en) Voir,s.v.p.,le papier ci joint avec le titre &#34;process for the preparation of disubstituted phenol ethers of 3-amino-2-hydroxypropane,with cerebrovascular activity,application of same for the preparation of pharmaceutical compositions with cerebrovascular activity and application of these pharmaceutical compositions in the treatment of cerebrovascular insufficiency&#34;
NL139739B (en) PROCEDURE FOR PREPARING THERAPEUTIC ACTIVE 3,4,5-TRIMETHOXYBENZOIC ACID AMIDES, PROCEDURE FOR PREPARING PHARMACEUTICAL PREPARATIONS CONTAINING THESE COMPOUNDS AND FORMED PHARMACEUTICAL PREPARATIONS, RECEIVED UNDER APPLICATION.
IE35594B1 (en) N-(bicycloamino-alkanoyl)-anilines
GB1088466A (en) Medicaments comprising 5-nitrouracil
FR3383M (en) Camphene-phenol derivatives and pharmaceutical compositions containing them.
BE899277A (en) HIGH-RELEASE ANTIMYCOTICS WITH ACTIVE SUBSTANCE IN THE FORM OF A SOLUTION AND SPRAY.
GB1110875A (en) Compositions containing procaine penicillins
ES383340A1 (en) P-(acetoacetamidoalkyl)benzenesulfonamide derivatives
FI49502C (en) Process for the preparation of N-substituted 1,4-dihydro-3-carboxy-cycloalkanoquinolones (4) having antimidribly active activity
FR3392M (en) Dermatological medicinal product, in particular for the treatment of oozing eczema.
AR196992A1 (en) BIOLOGICALLY ACTIVE COMPOSITIONS BASED ON 2-CHLOROALYL 2,5-DIMETHYL-1-PYRROLIDINECARBODITIOATE AND THE ACTIVE AGENT SUITABLE TO BE USED IN THESE
ES386775A1 (en) Urea derivative preparation
FR2954M (en) Aqueous pharmaceutical compositions sterilized in situ.
GB1008178A (en) Compositions containing nucleoside derivatives for treating coronary affections
FR2724M (en) Optionally 6-methylated oxapregn-4-ene-3,20-diones and their related derivatives, in particular α-homo, useful as progestational agents.
FR1601072A (en) Cpds. of the formula (I) and their acid addition salts R&#39; and R = H or CH3 R&#39; = CH3 only when DELTA4,5 present n = 1 or 2 H at 5 position
GB1194912A (en) Pharmaceutical Compositions Suitable for Cicatrization Processes and for the Treatment of Physiological Disorders of the Skin
Balashova et al. The use of oxylidin in psychiatric practice.
FR1320162A (en) Antiseptic and bactericidal composition diffused in aerosol form
FR1794M (en) Acetal-16 alpha, 17 alpha and ketal-16 alpha, 17 alpha derivatives of 16 alpha, 17 alpha steroids useful as progestational agents.